If improved even slightly, that is a positive sign suggesting adaptation is occurring
Doctors know what to expect, and side effects are usually manageable
As relatively new drugs with huge potential to help treat our obesity crisis and an ever-growing list of indications, GLP-1s may be truly valuable even at the high price for a given individual
We help patients decide whether medications like Wegovy, Zepbound, Ozempic, Mounjaro, Oral Wegovy, or Foundayo make sense for them, and we help patients understand emerging next-generation options such as retatrutide without confusing investigational data with an available prescription
The drugs efficacy is further enhanced when combined with agents like metreleptin, phentermine, and sibutramine